Cancer nanomedicine for therapy: emerging strategies and expanding perspectives
</br>![][1]</img> GUEST EDITOR Linqi Shi is a Professor and Ph.D. supervisor at the College of Chemistry (Nankai University, Tianjin, China). A recipient of the National Science Fund for Distinguished Young Scholars in 2006, Professor Shi later led an Innovative Team of the Ministry of
Authors
- Linqi Shi (ORCID: https://orcid.org/0000-0002-9534-795X)
Institutions
- Nankai University (CN)
- State Key Laboratory of Medicinal Chemical Biology
Publication Details
- Journal
- Cancer Biology and Medicine
- Published
- 2026-04-16
- DOI
- https://doi.org/10.20892/j.issn.2095-3941.2026.0254
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00